TD Asset Management Inc Makes New $192,000 Investment in NextGen Healthcare, Inc. (NASDAQ:NXGN)

TD Asset Management Inc purchased a new position in shares of NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 10,200 shares of the company’s stock, valued at approximately $192,000.

Other hedge funds also recently modified their holdings of the company. Strs Ohio boosted its stake in shares of NextGen Healthcare by 3.9% during the 3rd quarter. Strs Ohio now owns 45,300 shares of the company’s stock worth $801,000 after purchasing an additional 1,700 shares during the last quarter. Meritage Portfolio Management boosted its stake in shares of NextGen Healthcare by 3.6% during the 4th quarter. Meritage Portfolio Management now owns 19,632 shares of the company’s stock worth $369,000 after purchasing an additional 689 shares during the last quarter. Jump Financial LLC acquired a new stake in shares of NextGen Healthcare during the 3rd quarter worth about $389,000. Lazard Asset Management LLC boosted its stake in shares of NextGen Healthcare by 10,233.1% during the 3rd quarter. Lazard Asset Management LLC now owns 1,065,959 shares of the company’s stock worth $18,867,000 after purchasing an additional 1,055,643 shares during the last quarter. Finally, Rice Hall James & Associates LLC acquired a new stake in shares of NextGen Healthcare during the 3rd quarter worth about $5,898,000. 73.70% of the stock is owned by institutional investors and hedge funds.

NextGen Healthcare Stock Performance

NASDAQ NXGN opened at $16.69 on Friday. NextGen Healthcare, Inc. has a one year low of $16.13 and a one year high of $21.99. The company’s 50 day moving average price is $17.23 and its 200 day moving average price is $18.38. The company has a debt-to-equity ratio of 0.64, a quick ratio of 2.53 and a current ratio of 2.53. The firm has a market capitalization of $1.10 billion, a price-to-earnings ratio of 47.69 and a beta of 1.04.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on NXGN shares. StockNews.com started coverage on shares of NextGen Healthcare in a report on Thursday, March 16th. They set a “buy” rating on the stock. Stephens started coverage on shares of NextGen Healthcare in a report on Tuesday, April 11th. They set an “overweight” rating and a $24.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $22.25.

NextGen Healthcare Company Profile

(Get Rating)

NextGen Healthcare, Inc provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange.